Zdrowie i gospodarka · 31/05/2013
FDA Seeks Public Input on New Approaches to Antibacterial Drug Development
The FDA's Center for Drug Evaluation and Research is soliciting comments on potential new study designs, priorities for guidance documents, and strategies to combat emerging antibiotic resistance.
Source: Federal Register — Food and Drug AdministrationOpen original release →